Centessa IPO Presentation Deck
ROADSHOW MATERIALS IS STRICTLY PROHIBITED
IP ADDRESS. 51.89.224.65
2021 Expected Milestones
Data Readouts
ApcinteX
Phase 2a repeat dose study
OF
ROADSHOW MATERIALS IS STRICTLY PROHIBITED
P ADDRESS 51,80Z Factor
Phase 1 study
Palladio Biosciences.com
Alert study (Rolling)
Study Initiations
ApcinteX
48-week OLE study
PRINTING, COPYING, AND DISTRIBUTION OF
ROADSHOW MATERIALS IS STRICTLY PROHIBITED
IP ADDRESS: 51.89.224.65
Pega-One
Phase 2 study
Z Factor
US IND COPYING, AND DISTRIBUTION OF
51.89.224.65
CONF
IP ADDRESS: 51.69.224.65
IP ADDRESS 51.89.224.65
Pre-clinical Progress
PRINTING, COPYING AND DISTRIBUTION OF
ROADSHOW MATERIALS IS STRICTLY PROHIBIT
Janpix
Candidate Selection.com
Pearl River Bio
Candidate Selection
CENTESSA 3:0View entire presentation